Correction: AMG-232 sensitizes high MDM2-expressing tumor cells to T-cell-mediated killing

Ilyas Sahin; Shengliang Zhang; Arunasalam Navaraj; Lanlan Zhou; Don Dizon; Howard Safran; Wafik S El-Deiry

doi:10.1038/s41420-020-00310-1

Correction: AMG-232 sensitizes high MDM2-expressing tumor cells to T-cell-mediated killing

Cell Death Discov. 2020 Aug 7:6:71. doi: 10.1038/s41420-020-00310-1. eCollection 2020.

Authors

Ilyas Sahin^#^{1

2}, Shengliang Zhang^#^{1

3

4}, Arunasalam Navaraj^{1

3}, Lanlan Zhou^{1

3

4}, Don Dizon^{1

2

4}, Howard Safran^{1

2

4}, Wafik S El-Deiry^{1

2

3

4}

Affiliations

¹ Joint Program in Cancer Biology, Brown University and Lifespan Health System, Providence, RI USA.
² Division of Hematology/Oncology, The Warren Alpert Medical School, Brown University, Providence, RI USA.
³ Department of Pathology & Laboratory Medicine, The Warren Alpert Medical School, Brown University, Providence, RI USA.
⁴ Cancer Center at Brown University, The Warren Alpert Medical School, Brown University, Providence, RI USA.

^# Contributed equally.

Abstract

[This corrects the article DOI: 10.1038/s41420-020-0292-1.].

Keywords: Cancer immunotherapy; Drug development.

Publication types

Published Erratum